Intas, Accord BioPharma Acquire UDENYCA to Expand Globally
August 7, 2025
Intas Pharmaceuticals, along with its global subsidiaries under the Accord brand, has expanded its leadership in the biosimilar market with the acquisition of UDENYCA (pegfilgrastim-cbqv)